Abstract
Antipsychotics are the main treatment of schizophrenia. However, almost half of patients do not respond adequately to these drugs, and most individuals affected by the disease give up treatment due to the severe side effects. Consequently, mental functions become progressively worse, rendering patients unable to live in society permanently. We aim is to establish a commercially viable tes…